Fast Five Quiz: The Epidemiology of Psoriatic Arthritis

Eric Ruderman, MD


March 10, 2022

Patients with PsA commonly develop comorbidities, further contributing to disease burden. The most prevalent comorbidities are hypertension, metabolic syndrome, obesity, hyperlipidemia, and cardiovascular disease. The risk for adverse events is greatly reduced with appropriate treatment and modification of risk factors, highlighting the importance of early diagnosis and appropriate treatment.

The prevalence of pulmonary disease, depression, and inflammatory bowel disease is higher in patients with PsA as compared with the general population, but to a lesser degree. While not as common, depression is an important comorbid condition to recognize in patients with psoriasis and PsA.

Learn more about PsA.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.